Blog

Oct 31, 2024, 14:31

Development of TLS in different tumor sites from patients with high-grade serous ovarian cancer – Cancer Research Institute

Cancer Research Institute shared a post on LinkedIn:

“Aiming to improve the understanding of immune cell organization in ovarian cancer, a new study from researchers including CRI-Irvington Postdoctoral Fellow Dr. Ayana Ruffin of Emory University and former CRI-V Foundation CLIP Investigator Dr. Tullia Bruno of University of Pittsburgh sheds light on the development of tertiary lymphoid structures (TLS) in different tumor sites from patients with high-grade serous ovarian cancer.

Explore their findings, and discover how their insights could eventually lead to new treatment approaches for ovarian cancer.”

Ayana Ruffin cancer cancer awareness cancer care Cancer Research Institute CRI Emory University fight against cancer Global fight against cancer OncoDaily Oncology tertiary lymphoid structures (TLS) TLS Tullia Bruno University of Pittsburgh

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Bispecific Antibody M701 Offers a Novel Treatment Option for Malignant Ascites

Special Coverage